Inspire Medical Systems, Inc.

NYSE:INSP

Medical - Devices

Healthcare
$58.11 +1.24%

+$0.51 today

Market cap
$1.68B
Beta
0.73
P/E (TTM)
9.1
EPS (TTM)
$4.57
52W Low $38.91High $147.03

Volume 0.51M

Average 1.13M

INSP Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Inspire Medical Systems, Inc.NYSE: INSP

Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026

Stock-based compensation declines year over year

Q2 FY2026 stock-based compensation of $31.23M fell 25.2% year over year, behind the -8.2% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 1.7% from the prior quarter. Over 3 fiscal years it compounded at +35.8% a year.

Context

  • Stock-based compensation amounted to 14.3% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Stock-based compensation increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -25.2% toward the trailing-twelve-month pace of -8.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$31.23M+1.7% QoQ
Last fiscal yearDec 2025
$130.26M+12.3% YoY
LTMJun 2026
$119.43M-8.2% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-25.2%——
1 year+12.3%——
3-year CAGR+35.8%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
130.26M USD
Year-over-year change
+12.3%
4-year CAGR
+49.4%

Stock-Based Compensation vs competitors

How INSP compares with its peers on the latest reported figures

  • INSP's LTM Jun 2026 stock-based compensation of $119.43M is the largest of the 9 companies compared; the peer median is $26.25M.
  • Its year-over-year change of -8.2% is the 7th highest of 9, against a peer median of +17.9%.
  • Stock-based compensation amounts to 13.3% of revenue for INSP, versus a peer median of 1.8%.
INSP Competitors Peer median
Stock-Based Compensation for INSP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INSPInspire Medical Systems, Inc.LTM Jun 2026$119.43M -8.2%+35.8%13.3%
RCUSArcus Biosciences, Inc.LTM Jun 2026$63M -6.0%-2.6%53.8%
BKDBrookdale Senior Living Inc.LTM Sep 2026$51.51M +289.2%-6.2%1.7%
PRCTPROCEPT BioRobotics CorporationLTM Mar 2026$50.57M +41.7%+66.4%15.7%
ARDTArdent Health Partners, LLCLTM Mar 2026$29.29M +216.2%+300.6%0.5%
ADUSAddus HomeCare CorporationLTM Jun 2026$23.22M +74.9%+15.6%1.6%
ITGRInteger Holdings CorporationLTM Jul 2026$22.73M -7.9%+3.4%1.2%
AORTArtivion, Inc.LTM Mar 2026$8.41M -44.1%+25.5%1.8%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$5.78M -17.5%+23.3%2.3%
Peer median (excluding INSP) $26.25M+17.9%+19.5%1.8%

Competitors are the stored peer set for INSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(42.04M)(44.88M)(21.15M)53.51M145.42M
Depreciation & Amortization1.22M1.86M2.85M6.55M13.96M
Deferred Income Tax0000(88.75M)
Stock-Based Compensation26.18M51.97M82.47M116.01M130.26M
Change in Working Capital(6.86M)1.81M(40.78M)(37.71M)(87.38M)
Accounts Receivables(9.24M)(27.02M)(30.22M)(2.6M)(26.23M)
Inventory(8.75M)5.35M(22M)(46.23M)(65.18M)
Accounts Payables4.78M14.36M9.3M604K(3.75M)
Other Working Capital6.36M9.13M2.14M10.52M7.77M
Other Non-Cash Items1.38M812K1.27M(7.51M)3.47M
Operating Cash Flow(20.12M)11.57M24.65M130.25M116.98M
Capital Expenditures(4.67M)(9.1M)(23.63M)(39.12M)(38.5M)
Acquisitions (Net)00000
Purchases of Investments(9.99M)0(281.44M)(418.6M)(250.44M)
Sales of Investments43.8M010.25M344.61M310.38M
Other Investing Activities0(10.5M)000
Investing Cash Flow29.14M(19.6M)(294.82M)(113.12M)21.45M
Debt Repayment0(24.5M)000
Common Stock Issued14.95M259.62M31.11M27.77M14.61M
Common Stock Repurchased000(75M)(175.02M)
Dividends Paid00000
Other Financing Activities0(43K)(17.16M)(5.17M)(23.04M)
Financing Cash Flow14.95M235.08M13.95M(52.39M)(183.45M)
Effect of Forex Changes(19K)75K164K(118K)(310K)
Net Change in Cash23.95M227.13M(256.06M)(35.39M)(45.34M)
Free Cash Flow(24.79M)2.47M1.02M91.12M78.48M

Inspire Medical Systems, Inc.

NYSE:INSP

Intrinsic Alpha fair value

Locked

Current Price

$58.11

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.